WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science, announced
that it will present at the 2008 Merrill Lynch Global Pharmaceutical,
Biotechnology & Medical Device Conference being held at the Grand Hyatt
Hotel in New York City. The company will present on Thursday, February 7,
2008, at 9:20 am (EST).
Marijn E. Dekkers, president and chief executive officer of Thermo
Fisher Scientific, will provide an overview of the company and discuss its
expectations for future financial performance.
You may listen to the presentation live on our Website,
http://www.thermofisher.com, by clicking on "Investors." An audio archive
of the Webcast will be available in that section of our Website under
"Webcasts and Presentations" through Friday, March 7, 2008.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With an annual revenue rate of more than $9 billion, we
employ 30,000 people and serve over 350,000 customers within pharmaceutical
and biotech companies, hospitals and clinical diagnostic labs,
universities, research institutions and government agencies, as well as
environmental and industrial process control settings. Serving customers
through two premier brands, Thermo Scientific and Fisher Scientific, we
help solve analytical challenges from routine testing to complex research
and discovery. Thermo Scientific offers customers a complete range of
high-end analytical instruments as well as laboratory equipment, software,
services, consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
Media Contact Information:
Karen Kirkwood
Phone: 781-622-1306
E-mail: Karen.Kirkwood@thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1111
E-mail: ken.apicerno@thermofisher.com
Website: http://www.thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com
http://www.prnewswire.com/comp/877850.html /
CONTACT:
Media, Karen Kirkwood, +1-781-622-1306,
Karen.Kirkwood@thermofisher.com, or Investors, Ken Apicerno,
+1-781-622-1111, ken.apicerno@thermofisher.com, both of Thermo
Fisher Scientific Inc.
|
